Elexacaftor - Tezacaftor - Ivacaftor treatment improves systemic infection parameters and Pseudomonas aeruginosa colonization rate in patients with cystic fibrosis a monocentric observational study.
Heliyon（2023）
摘要
ETI treatment effectively improves systemic inflammation parameters and shows promising results in PsA status conversion.
更多查看译文
关键词
cystic fibrosis,pseudomonas aeruginosa colonization rate,pseudomonas aeruginosa,systemic infection parameters,ivacaftor treatment
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要